Skip to main
IQV

IQVIA Hlds (IQV) Stock Forecast & Price Target

IQVIA Hlds (IQV) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 40%
Buy 53%
Hold 7%
Sell 0%
Strong Sell 0%

Bulls say

IQVIA Holdings is experiencing notable growth in its Functional Service Provider (FSP), Real World Evidence (RWE), and Commercial Solutions and Medical Services (CSMS) segments, all of which demonstrated year-over-year growth in the third quarter. The company is benefiting from improved client decision timelines and a robust pipeline, bolstered by recent drug launches, which enhances its commercial momentum. Additionally, IQVIA's positive outlook is further supported by an anticipated growth rate of over 4% for its Research and Development Solutions (R&DS) segment on a constant currency basis, alongside an improved pricing environment.

Bears say

The financial analysis of IQVIA Holdings reveals a concerning trend in year-over-year constant currency (CC) growth, which has declined from 6.8% in the previous quarter to 3.8%, signaling a potential slowdown in revenue growth against tough comparisons. The company has expressed disappointment over any projected revenue growth falling below 5% for 2026, raising doubts about its ability to meet market expectations amid increasing challenges. Additionally, the impact of rising interest rates poses a risk to earnings, further complicating the outlook for IQVIA and contributing to a cautious perspective on its financial performance.

IQVIA Hlds (IQV) has been analyzed by 15 analysts, with a consensus rating of Buy. 40% of analysts recommend a Strong Buy, 53% recommend Buy, 7% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of IQVIA Hlds and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About IQVIA Hlds (IQV) Forecast

Analysts have given IQVIA Hlds (IQV) a Buy based on their latest research and market trends.

According to 15 analysts, IQVIA Hlds (IQV) has a Buy consensus rating as of Apr 23, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $230.47, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $230.47, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

IQVIA Hlds (IQV)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.